| DG01899 | |
| DG number | DG01899 |
| Classification | DGroup |
| Name | Antiinflammatory drug, indoleacetic acid derivatives |
| Stem | - |
| Structural formula |  |
| Member | DG00241 Indometacin D00141 Indomethacin (USP); Indometacin (JP17/INN) D01565 Indometacin farnesil (JAN) D02110 Indomethacin sodium (USP); Indometacin sodium (JAN) DG00750 Proglumetacin D08427 Proglumetacin (INN) D01765 Proglumetacin maleate (JAN) D01582 Acemetacin (JP17/INN) D07266 Oxametacin (INN) D05995 Talmetacin (USAN/INN) D06364 Zidometacin (USAN/INN) |
| Upper group | Anti-inflammatory DG01906 Antiinflammatory drug, acetic acid derivatives DG01504 Nonsteroidal antiinflammatory drug (NSAID) DG01906 Antiinflammatory drug, acetic acid derivatives |
| Remark | - |
| Comment | Cyclooxygenase 2 (COX-2) inhibitor, Antiinflammatory drug, acetic acid derivatives |
| Target | PTGS2 (COX2) [HSA:5743] [KO:K11987] |
| Metabolism | - |
| Interaction | - |